Actual psychotropic medication use in preschool children

Infants and Young Children

Volumn 19, Issue 2, 2006, Pages 154-163

  Rappley, Marsha D ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Clonidine; Mental health; Methylphenidate; Preschool; Psychotropic medications; Riperidone

Indexed keywords

EID: 33749450002     PISSN: 08963746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001163-200604000-00008     Document Type: Review

References (37)

1. Barkley, R. A., Shelton, T. L., Crosswait, C., Moorehouse, M., Fletcher, K., Barrett, S., et al. (2002). Preschool children with disruptive behavior: Three-year outcome as a function of adaptive disability. Development and Psychopathology, 14(1), 45-67.
2. Borr, W., Sanders, M., & Markie-Dadds, C. (2002). The effects of the triple P-positive parenting program on preschool children with co-occurring disruptive behavior and attentional/hyperactive difficulties. Journal of Abnormal Child Psychology, 30(6), 571-587.
3. Campbell, S. B. (1987). Parent-referred problem three-year-olds: Developmental changes in symptoms. Journal of Child Psychology and Psychiatry and Allied Disciplines, 28(6), 835-845.
4. Campbell, S. B. (1995). Behavior problems in preschool children: A reviewof recent research. Journal of Child Psychology and Psychiatry and Allied Disciplines, 36(1), 113-149.
5. Chronis, A. M., Lahey, B. B., Pelham, W. E., Jr., Kipp, H. L., Baumann, B. L., & Lee, S. S. (2003). Psychopathology and substance abuse in parents of young children with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 42(12), 1424-1432.
6. Cooper, W. O., Hickson, G. B., Fuchs, C., Arbogast, P. G., & Ray, W. A. (2004). New users of antipsychotic medications among children enrolled in TennCare. Archives of Pediatrics and Adolescent Medicine, 158(8), 753-759.
7. Croonenberghs, J., Fegert, J. M., Findling, R. L., De Smedt, G., & Van Dongen, S. (2005). Risperidone in children with disruptive behavior disorders and subaverage intelligence: A 1-year, open-label study of 504 patients. Journal of the American Academy of Child and Adolescent Psychiatry, 44(1), 64-72.
8. DeBar, L. L., Lynch, F., Powell, J., & Gale, J. (2003). Use of psychotropic agents in preschool children: Associated symptoms, diagnoses, and health care services in a health maintenance organization. Archives of Pediatrics and Adolescent Medicine, 157(2), 150-157.
9. DuPaul, G. J., McGoey, K. E., Eckert, T. L., & VanBrakle, J. (2001). Preschool children with attention-deficit/hyperactivity disorder: Impairments in behavioral, social, and school functioning. Journal of the American Academy of Child and Adolescent Psychiatry, 40(5), 508-515.
10. Fankhauser, M. P., Karumanchi, V. C., German, M. L., Yates, A., & Karumanchi, S. D. (1992). A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. Journal of Clinical Psychiatry, 53(3), 77-82.
11. Findling, R. L., Aman, M. G., Eerdekens, M., Derivan, A., & Lyons, B. (2004). Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ. American Journal of Psychiatry, 161(4), 677-684.
12. Fritz, G., & Rockney, R. (2004). Summary of the practice parameter for the assessment and treatment of children and adolescents with enuresis. Journal of the American Academy of Child and Adolescent Psychiatry, 43(1), 123-125.
13. Gadow, K. D. (1976). Psychotropic and anticonvulsant drug use in early childhood special education programs. I. Phase one: A preliminary report: Prevalence, attitude, training and problems. Chicago: Institute for Child Behavior and Development, Council for Exceptional Children.
14. Gadow, K. D., & Nolan, E. E. (2002). Differences between preschool children with ODD, ADHD, and ODD + ADHD symptoms. Journal of Child Psychology and Psychiatry and Allied Disciplines, 43(2), 191-201.
15. Gadow, K. D., Sprafkin, J., & Nolan, E. E. (2001). DSMIV Symptoms in community and clinic preschool children. Journal of the American Academy of Child and Adolescent Psychiatry, 40(12), 1383-1392.
16. Gagliano, A., Germano, E., Pustorino, G., Impallomeni, C., D'Arrigo, C., Calamoneri, F., et al. (2004). Risperidone treatment of children with autistic disorder: Effectiveness, tolerability, and pharmacokinetic implications. Journal of Child and Adolescent Psychopharmacology, 14(1), 39-47.
17. Ghuman, J. K., Ginsburg, G. S., Subramaniam, G., Ghuman, H. S., Kau, A. S., & Riddle, M. A. (2001). Psychostimulants in preschool children with attention-deficit/hyperactivity disorder: Clinical evidence from a developmental disorders institution. Journal of the American Academy of Child and Adolescent Psychiatry, 40(5), 516-524.
18. Jaselskis, C. A., Cook, E. H., Jr., Fletcher, K. E., & Leventhal, B. L. (1992). Clonidine treatment of hyperactive and impulsive children with autistic disorder. Journal of Clinical Psychopharmacology, 12(5), 322-327.
19. Lahey, B. B., Pelham, W. E., Stein, M. A., Loney, J., Trapani, C., & Nugent, K., et al. (1998). Validity of DSM-IV attention-deficit/hyperactivity disorder for younger children. Journal of the American Academy of Child and Adolescent Psychiatry, 37(7), 695-702.
20. Masi, G., Cosenza, A., Mucci, M., & Brovedani, P. (2003). A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone. Journal of Clinical Psychiatry, 64(9), 1039-1047.
21. Masi, G., Cosenza, A., Mucci, M., & De Vito, G. (2001). Risperidone monotherapy in preschool children with pervasive developmental disorders. Journal of Child Neurology, 16(6), 395-400.
22. McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., et al. (2002). Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine, 347(5), 314-321.
23. Michael, J. B., & Sztajnkrycer, M. D. (2004). Deadly pediatric poisons: Nine common agents that kill at low doses. Emergency Medicine Clinics of North America, 22(4), 1019-1050.
24. Mukaddes, N. M., Abali, O., & Gurkan, K. (2004). Short-term efficacy and safety of risperidone in young children with autistic disorder (AD). World Journal of Biological Psychiatry, 5(4), 211-214.
25. Rappley, M., Eneli, I., Mullan, P., Alvarez, F., Wang, J., Luo, Z., et al. (2002). Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder. Journal of Developmental and Behavioural Pediatrics, 23(1), 23-30.
26. Rappley, M., Mullan, P., Alvarez, F., Eneli, I., Wang, J., & Gardiner, J. (1999). Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children. Archives of Pediatrics and Adolescent Medicine, 153, 1039-1045.
27. Rietveld, M. J., Hudziak, J. J., Bartels, M., van Beijsterveldt, C. E., & Boomsma, D. I. (2004). Heritability of attention problems in children: Longitudinal results from a study of twins, age 3 to 12. Journal of Child Psychology and Psychiatry and Allied Disciplines, 45(3), 577-588.
28. Robert, R., Blakeney, P. E., Villarreal, C., Rosenberg, L., & Meyer, W. J., III. (1999). Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder: A pilot study. Journal of the American Academy of Child and Adolescent Psychiatry, 38(7), 873-882.
29. Rushton, J. L., & Whitmire, J. T. (2001). Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998. Archives of Pediatrics and Adolescent Medicine, 155(5), 560-565.
30. Safer, D. J., Zito, J. M., & DosReis, S. (2003). Concomitant psychotropic medication for youths. American Journal of Psychiatry, 160(3), 438-449.
31. Shea, S., Turgay, A., Carroll, A., Schulz, M., Orlik, H., Smith, I., et al. (2004). Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics, 114(5), e634-e641.
32. Sinkovits, H. S., Kelly, M., & Ernst, M. (2003). Medication administration in day care centers for children. Journal of the American Pharmacists Association, 43(3), 379-382.
33. Snyder, R., Turgay, A., Aman, M., Binder, C., Fisman, S., & Carroll, A. (2002). Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. Journal of the American Academy of Child and Adolescent Psychiatry, 41(9), 1026-1036.
34. Sonuga-Barke, E., Daley, D., Thompson, M., Laver-Bradbury, C., & Weeks, A. (2001). Parent-based therapies for preschool attention-deficit/ hyperactivity disorder: A randomized, controlled trial with a community sample. Journal of the American Academy of Child and Adolescent Psychiatry, 40(4), 402-408.
35. Wilens, T. E., Biederman, J., Baldessarini, R. J., Geller, B., Schleifer, D., Spencer, T. J., et al. (1996). Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 35(11), 1491-1501.
36. Wilens, T. E., Biederman, J., Brown, S., Monuteaux, M., Prince, J., & Spencer, T. J. (2002). Patterns of psychopathology and dysfunction in clinically referred preschoolers. Journal of Developmental and Behavioral Pediatrics, 23(1, Suppl.), S31-S36.
37. Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Boles, M., & Lynch, F. (2000). Trends in the prescribing of psychotropic medications to preschoolers. JAMA, 283(8), 1025-1030.